Fig. 9

Kaplan–Meier survival curves of different tumor types of patients in TCGA dataset. A Overall survival plot of SIRT6 in all 17 types of tumors (n = 4678, logrank P < 0.05); B Disease-free survival plot of SIRT6 in all 17 types of tumors (n = 2828, logrank P = 0.164); C Overall survival plot of SIRT6 in gastrointestinal cancer (n = 609, logrank P < 0.05); D Disease-free survival plot of SIRT6 in gastrointestinal cancer (n = 260, logrank P < 0.05); E Overall survival plot of SIRT6 in breast cancer (n = 1082, logrank P = 0.826); F Disease-free survival plot of SIRT6 in breast cancer (n = 952, logrank P < 0.05); G Overall survival plot of SIRT6 in head and neck cancer (n = 1010, logrank P < 0.05); H Disease-free survival plot of SIRT6 in head and neck cancer (n = 482, logrank P = 0.583); I Overall survival plot of SIRT6 in urogenital cancer (n = 2130, logrank P < 0.05); J Disease-free survival plot of SIRT6 in urogenital cancer (n = 1109, logrank P < 0.05); K Overall survival plot of SIRT6 in other system cancer (n = 401, logrank P < 0.05); L Disease-free survival plot of SIRT6 in other system cancer (n = 25, logrank P = 0.149)